IL17A and rheumatoid arthritis: Surprisingly, however, anti-IL-17 treatment showed efficacy against PS, PsA, and AS in a number of clinical trials [26], indicating a role for IL-17 in the inflammation of the enthesis (connective tissue between tendon and its ligament), rather than the synovium, which is characteristics of RA [27].